Evidence map›Paper›PMID 26081042›Full record

ArticleNature communications2015

Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch.

Irene Maria Aspalter, Emma Gordon, Alexandre Dubrac, Anan Ragab, Jarek Narloch, Pedro Vizán, Ilse Geudens, Russell Thomas Collins, Claudio Areias Franco, Cristina Luna Abrahams and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 168 citations in OpenAlex.

  1. Cell-to-Cell Signaling Networks at the Blood-Brain Barrier in Health and Disease.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Development of the blood-brain barrier.Development (Cambridge, England) · 2026
    Review
  7. Article
  8. Dissecting endothelial cell heterogeneity with new tools.Cell regeneration (London, England) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Biology of vascular mural cells.Development (Cambridge, England) · 2023
    Review
  18. Review
  19. Fibrillin-1 regulates endothelial sprouting during angiogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 6 countries.

Irene Maria AspalterVascular Biology Laboratory, London Research Institute, Cancer Research UK, London WC2A 3LY, UK.
Emma GordonYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Alexandre DubracYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA.ORCID http://orcid.org/0000-0002-3829-2577
Anan RagabVascular Biology Laboratory, London Research Institute, Cancer Research UK, London WC2A 3LY, UK.
Jarek NarlochTransgenic Services, London Research Institute-Clare Hall Laboratories, Cancer Research UK, Potters Bar EN6 3LD, UK.
Pedro VizánDevelopmental Signalling Laboratory, London Research Institute, Cancer Research UK, London WC2A 3LY, UK.
Ilse GeudensVascular Patterning Laboratory, Vesalius Research Center, VIB, KU Leuven B-3000, Belgium.
Russell Thomas CollinsVascular Biology Laboratory, London Research Institute, Cancer Research UK, London WC2A 3LY, UK.
Claudio Areias FrancoVascular Biology Laboratory, London Research Institute, Cancer Research UK, London WC2A 3LY, UK.
Cristina Luna AbrahamsRegeneron Pharmaceuticals, Tarrytown, New York 10591, USA.
Gavin ThurstonRegeneron Pharmaceuticals, Tarrytown, New York 10591, USA.
Marcus FruttigerUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Ian RosewellTransgenic Services, London Research Institute-Clare Hall Laboratories, Cancer Research UK, Potters Bar EN6 3LD, UK.
Anne EichmannYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Holger GerhardtVascular Biology Laboratory, London Research Institute, Cancer Research UK, London WC2A 3LY, UK.
Cancer Research UK · GBMax Delbrück Center · DERegeneron (United States) · USYale University · USInserm · FRUniversitat Pompeu Fabra · ESUniversity College London · GBVIB-KU Leuven Center for Cancer Biology · BE

Funding

Targeting endothelial migration to prevent neovascularizationR01HL125811 · NHLBI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2025
$4.1M
Novel approaches to manipulate sprouting angiogenesisR01EY025979 · NEI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2019
$1.9M
Role of Neuropilin receptors in lymphangiogenesisR01HL111504 · NHLBI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2012 to 2015
$1.6M
Cancer Research UKEuropean Research Council 311719NEI NIH HHS R01 EY025979NHLBI NIH HHS NIH R01 HL 111504-02NHLBI NIH HHS R01 HL111504NHLBI NIH HHS R01 HL125811
6 · The paper itself

Abstract

Sprouting angiogenesis drives blood vessel growth in healthy and diseased tissues. Vegf and Dll4/Notch signalling cooperate in a negative feedback loop that specifies endothelial tip and stalk cells to ensure adequate vessel branching and function. Current concepts posit that endothelial cells default to the tip-cell phenotype when Notch is inactive. Here we identify instead that the stalk-cell phenotype needs to be actively repressed to allow tip-cell formation. We show this is a key endothelial function of neuropilin-1 (Nrp1), which suppresses the stalk-cell phenotype by limiting Smad2/3 activation through Alk1 and Alk5. Notch downregulates Nrp1, thus relieving the inhibition of Alk1 and Alk5, thereby driving stalk-cell behaviour. Conceptually, our work shows that the heterogeneity between neighbouring endothelial cells established by the lateral feedback loop of Dll4/Notch utilizes Nrp1 levels as the pivot, which in turn establishes differential responsiveness to TGF-β/BMP signalling.

Indexed as

Activin Receptors, Type IActivin Receptors, Type IIAnimalsEndothelium, VascularGrowth Differentiation Factor 2HumansHuman Umbilical Vein Endothelial CellsIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceNeuropilin-1PhenotypeProtein Serine-Threonine KinasesReceptors, NotchReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IActivin Receptors, Type IActivin Receptors, Type IIAcvrl1 protein, mousedelta proteinGdf2 protein, mouseGrowth Differentiation Factor 2Intracellular Signaling Peptides and ProteinsMembrane ProteinsNeuropilin-1Protein Serine-Threonine KinasesReceptors, NotchReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ISmad2 ProteinSmad3 ProteinTGFBR1 protein, humanTgfbr1 protein, mouse

Identifiers

PMID26081042
PMCPMC4557308
OpenAlexW2266281003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.